Inogen offers initial sale of 3,529,411 shares from $16.00 to $18.00

Medical technology company will sell stock via bookrunner JPMorgan

By Devika Patel

Knoxville, Tenn., Feb. 4 - Inogen, Inc. will sell 3,529,411 common shares in its initial public sale with selling stockholders selling 882,352 and a 30-day greenshoe of 661,764 additional shares, according to a Form S-1/A filed Tuesday with the Securities and Exchange Commission. The deal was announced Nov. 27.

The shares will be sold at a price expected to fall between $16.00 and $18.00 per share.

JPMorgan is the bookrunning manager, Leerink Swann is the lead manager and William Blair and Stifel are the co-managers.

Proceeds will be used for investments in rental assets, sales and marketing, research and product development; facility improvements or expansions and to purchase manufacturing and other equipment; and for working capital and other general corporate purposes.

The medical technology company is based in Goleta, Calif. The company expects its shares will trade on the Nasdaq under the symbol "INGN."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.